CLINICAL TRIALS PROFILE FOR METROGEL-VAGINAL

All Clinical Trials for METROGEL-VAGINAL

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01020396 ↗	Bioequivalence of Metronidazole Gel, 0.75% in the Treatment of Bacterial Vaginosis	Completed	Teva Pharmaceuticals USA	Phase 1/Phase 2	2002-01-01	The purpose of this study was to demonstrate comparable efficacy, safety, and tolerability of Teva Pharmaceuticals USA's generic formulation of Metronidazole Vaginal Gel, 0.75% and 3M Pharmaceuticals' MetroGel-Vaginal® metronidazole vaginal gel, 0.75% to establish clinical equivalence in the treatment of bacterial vaginosis.
NCT01020877 ↗	Bioavailability of Metronidazole Vaginal Gel in Healthy Subjects	Completed	Teva Pharmaceuticals USA	Phase 1	2001-11-01	The primary object of this study was to evaluate the relative bioavailability of the test formulation of metronidazole vaginal gel with the already marketed reference formulation MetroGel-Vaginal Gel® in healthy adult female subjects.
NCT02376972 ↗	Efficacy and Safety Study of Rifaximin Vaginal Tablets in Bacterial Vaginosis	Terminated	Parexel	Phase 2	2015-04-01	THE STUDY HAS BEEN DESIGNED TO COMPARE THE EFFICACY OF TWO DOSES (25 MG AND 100 MG) OF RIFAXIMIN VAGINAL TABLETS VERSUS PLACEBO IN SUBJECTS WITH BACTERIAL VAGINOSIS

Clinical Trial Conditions for METROGEL-VAGINAL

Condition Name

Condition Name for METROGEL-VAGINAL
Intervention	Trials
Bacterial Vaginosis	3
Healthy	1
Post-Op Infection	1

Condition MeSH

Condition MeSH for METROGEL-VAGINAL
Intervention	Trials
Vaginosis, Bacterial	3
Vaginal Diseases	3

Clinical Trial Locations for METROGEL-VAGINAL

Trials by Country

Trials by Country for METROGEL-VAGINAL
Location	Trials
United States	23

Trials by US State

Trials by US State for METROGEL-VAGINAL
Location	Trials
Pennsylvania	3
New York	2
Illinois	2
California	2
New Jersey	1

Clinical Trial Progress for METROGEL-VAGINAL

Clinical Trial Phase

Clinical Trial Phase for METROGEL-VAGINAL
Clinical Trial Phase	Trials
Phase 4	1
Phase 2	2
Phase 1/Phase 2	1

Clinical Trial Status

Clinical Trial Status for METROGEL-VAGINAL
Clinical Trial Phase	Trials
Completed	3
Recruiting	1
Terminated	1

Clinical Trial Sponsors for METROGEL-VAGINAL

Sponsor Name

Sponsor Name for METROGEL-VAGINAL
Sponsor	Trials
Teva Pharmaceuticals USA	2
Parexel	1
Alfa Wassermann S.p.A.	1

Sponsor Type

Sponsor Type for METROGEL-VAGINAL
Sponsor	Trials
Industry	5
NIH	1
Other	1